Preview

Biological Products. Prevention, Diagnosis, Treatment

Advanced search

Biotechnological preparations as a means of improving the safety of pharmacotherapy: state of the art and prospects of development

Abstract

Development and improvement of biotechnological drugs currently more relevant than ever. Drugs obtained by means of biotechnology, have a number of positive qualities. Biotechnology allows you to create such products, which are currently impossible to synthesize by chemical means, in addition, the production of drugs using biotechnology meets the standards of quality, efficacy and safety and, more importantly, economically. Biotech drugs are used for treatment of infectious, autoimmune, cancer, are used to prevent, thereby finding wide application in medicine.

About the Authors

A. A. Lidzhieva
I. M. Sechenov First Moscow State Medical University
Russian Federation
Junior researcher of Department of introduction of new medicines of the Scientific Research Institute of Pharmacy


E. A. Smolyarchuk
I. M. Sechenov First Moscow State Medical University
Russian Federation
Head of Department of introduction of new medicines of the Scientific Research Institute of Pharmacy. Candidate of Medical Sciences


A. E. Kokorina
I. M. Sechenov First Moscow State Medical University
Russian Federation


V. V. Smirnov
I. M. Sechenov First Moscow State Medical University
Russian Federation
Docent of the Department of pharmaceutical and toxicological chemistry. Candidate of Pharmaceutical Sciences


E. A. Egorenkov
I. M. Sechenov First Moscow State Medical University
Russian Federation
Post-graduate student of the Department of pharmaceutical and toxicological chemistry


References

1. Volova TG. Biotechnology. Novosibirsk: Izdatelstvo Sibirskogo otdeleniya Rossiyskoy Akademii nauk; 1999 (in Russian).

2. Beker ME. Introduction to biotechnology. Moscow: Pischevaya promyshlennost; 1978 (in Russian).

3. Elinov NP. Basics of biotechnology. St. Petersburg: Nauka; 1995 (in Russian).

4. Katlinskiy AV, ed. Schoolbook for students of higher pharmaceutical education. 3rd ed. Moscow: Academia; 2008 (in Russian).

5. Egorov NS, Samuilov VD, ed. Biotechnology. Schoolbook for high schools in 8 books. Book 1. Problems and Prospects. Moscow: Vysshaya shkola; 1987 (in Russian).

6. Evtushenkov AN, Fomichev YuK. Introduction to biotechnology. Lecture course. Minsk: BGU; 2002 (in Russian).

7. Katlinskiy AV. Lecture course on biotechnology. Moscow: I. M. Sechenov MMA; 2005 (in Russian).

8. Glik IB, Pasternak J. Molecular biotechnology. Moscow: Mir; 2002 (in Russian).

9. WHO Library Cataloguing-in-Publication Data. The world health report 2013: research for universal health coverage.

10. Prischep TP, Chuchalin VS. Basics of pharmaceutical biotechnology. Rostov-on-Don: Feniks; 2006 (in Russian).

11. Sartakova OYu. Basics of microbiology and biotechnology. Part 1. Barnaul: AGTU; 2001 (in Russian).

12. Higgins I, ed. Biotechnology: principles and applications. Moscow: Mir; 1988 (in Russian).

13. Viestur UE, Shmite IA, Zhilevich AV. Biotechnology. Biological agents, technology, equipment. Riga: Zinatne; 1987 (in Russian).

14. Sartakova OYu. Basics of microbiology and biotechnology. Part 2. Barnaul: AGTU; 2005 (in Russian).

15. Egorov NS, Samuilov VD, ed. Biotechnology. Schoolbook for high schools in 8 books. Book 6. Microbiological production of biologically active substances and drugs. Moscow: Vysshaya shkola; 1987 (in Russian).

16. Egorov NS, Samuilov VD, ed. Biotechnology. Schoolbook for high schools in 8 books. Book 3. Cell engineering. Moscow: Vysshaya shkola; 1987 (in Russian).

17. Kuzmina NA. Basics of biotechnology. Schoolbook. Omsk; 2006 (in Russian).

18. Sadchenko LS. Recent advances of biotechnology in the medical industry. Moscow; 2008 (in Russian).

19. Gracheva IM. The technology of enzyme preparations. 3rd ed. Moscow: Elevar; 2000 (in Russian).

20. Egorova TA, Klunova SM. Zhivuhina EA. Basics of biotechnology. Moscow: Academia; 2003 (in Russian).

21. Dyatlova VI, Bogun AG, Biketov SF. Evaluating serodiagnostic potential of recombinant antigens Mycobacterium tuberculosis, produced in different expression systems. Biotehnologiya 2014; (1): 7278 (in Russian).

22. Ershler MA, Olovnikova NI. Production of monoclonal IgM antibodies in DG44 cells. Biotehnologiya 2014; (2): 24–34 (in Russian).

23. Smirnov V, Krasnykh L, Merkulov V, Bunyatyan N, Ramenskaya G, Eltsova E, Smolyarchuk E, Egorenkov E, Bushmanova A. World practice in the assessment of the interchangeability of bioengineered drugs. Vrach 2015; (9): 12–4 (in Russian).

24. Bushmanova AV, Eltsova EA, Ramenskaya GV, Smolyarchuk EA. Biosimilars — medicines of the future. Farmakokinetika i farmakodinamika 2015; (1): 14–7 (in Russian).


Review

For citations:


Lidzhieva A.A., Smolyarchuk E.A., Kokorina A.E., Smirnov V.V., Egorenkov E.A. Biotechnological preparations as a means of improving the safety of pharmacotherapy: state of the art and prospects of development. BIOpreparations. Prevention, Diagnosis, Treatment. 2016;16(3):145-150. (In Russ.)

Views: 1684


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2221-996X (Print)
ISSN 2619-1156 (Online)